Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

Similar articles for PubMed (Select 24651234)

1.

Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality.

Hästbacka J, Linko R, Tervahartiala T, Varpula T, Hovilehto S, Parviainen I, Vaara ST, Sorsa T, Pettilä V.

Anesth Analg. 2014 Apr;118(4):790-8. doi: 10.1213/ANE.0000000000000120.

PMID:
24651234
2.

Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.

Lauhio A, Hästbacka J, Pettilä V, Tervahartiala T, Karlsson S, Varpula T, Varpula M, Ruokonen E, Sorsa T, Kolho E.

Pharmacol Res. 2011 Dec;64(6):590-4. doi: 10.1016/j.phrs.2011.06.019. Epub 2011 Jul 1.

PMID:
21742038
3.

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

Lorente L, Martín MM, Labarta L, Díaz C, Solé-Violán J, Blanquer J, Orbe J, Rodríguez JA, Jiménez A, Borreguero-León JM, Belmonte F, Medina JC, Llimiñana MC, Ferrer-Agüero JM, Ferreres J, Mora ML, Lubillo S, Sánchez M, Barrios Y, Sierra A, Páramo JA.

Crit Care. 2009;13(5):R158. doi: 10.1186/cc8115. Epub 2009 Oct 2.

4.

Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.

Lorente L, Martín MM, López P, Ramos L, Blanquer J, Cáceres JJ, Solé-Violán J, Solera J, Cabrera J, Argueso M, Ortiz R, Mora ML, Lubillo S, Jiménez A, Borreguero-León JM, González A, Orbe J, Rodríguez JA, Páramo JA.

PLoS One. 2014 Apr 11;9(4):e94370. doi: 10.1371/journal.pone.0094370. eCollection 2014.

5.

Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation.

Kong MY, Li Y, Oster R, Gaggar A, Clancy JP.

PLoS One. 2011;6(8):e22596. doi: 10.1371/journal.pone.0022596. Epub 2011 Aug 3.

6.

Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients.

Nakamura T, Kawagoe Y, Matsuda T, Shoji H, Ueda Y, Tamura N, Ebihara I, Koide H.

Blood Purif. 2004;22(3):256-60. Epub 2004 May 12.

PMID:
15148453
7.

Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.

Lorente L, Martín MM, Solé-Violán J, Blanquer J, Labarta L, Díaz C, Borreguero-León JM, Orbe J, Rodríguez JA, Jiménez A, Páramo JA.

PLoS One. 2014 Apr 11;9(4):e94318. doi: 10.1371/journal.pone.0094318. eCollection 2014.

8.

SuPAR and PAI-1 in critically ill, mechanically ventilated patients.

Jalkanen V, Yang R, Linko R, Huhtala H, Okkonen M, Varpula T, Pettilä V, Tenhunen J; FINNALI Study Group.

Intensive Care Med. 2013 Mar;39(3):489-96. doi: 10.1007/s00134-012-2730-x. Epub 2012 Oct 26.

PMID:
23100007
9.

Impact of distinct definitions of acute lung injury on its incidence and outcomes in Brazilian ICUs: prospective evaluation of 7,133 patients*.

Caser EB, Zandonade E, Pereira E, Gama AM, Barbas CS.

Crit Care Med. 2014 Mar;42(3):574-82. doi: 10.1097/01.ccm.0000435676.68435.56.

PMID:
24158166
10.

Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.

Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, Clement B, Lagente V, Malledant Y.

Crit Care Med. 2003 Feb;31(2):536-42.

PMID:
12576963
11.

Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis.

Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, Huhle G, Borggrefe M, Brueckmann M.

Scand J Infect Dis. 2006;38(10):867-72.

PMID:
17008230
12.

Plasma neutrophil gelatinase-associated lipocalin and adverse outcome in critically ill patients with ventilatory support.

Linko R, Pettilä V, Kuitunen A, Korhonen AM, Nisula S, Alila S, Kiviniemi O, Laru-Sompa R, Varpula T, Karlsson S; FINNALI Study Investigators.

Acta Anaesthesiol Scand. 2013 Aug;57(7):855-62. doi: 10.1111/aas.12112. Epub 2013 Apr 4.

PMID:
23556459
13.

Serum zinc in critically ill adult patients with acute respiratory failure.

Linko R, Karlsson S, Pettilä V, Varpula T, Okkonen M, Lund V, Ala-Kokko T, Ruokonen E; FINNALI Study Group.

Acta Anaesthesiol Scand. 2011 May;55(5):615-21. doi: 10.1111/j.1399-6576.2011.02425.x.

PMID:
21827444
14.

Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.

Mühl D, Nagy B, Woth G, Falusi B, Bogár L, Weber G, Lantos J.

J Crit Care. 2011 Dec;26(6):550-5. doi: 10.1016/j.jcrc.2011.02.011. Epub 2011 May 6.

PMID:
21530151
15.

Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure.

Walkey AJ, Rice TW, Konter J, Ouchi N, Shibata R, Walsh K, deBoisblanc BP, Summer R.

Crit Care Med. 2010 Dec;38(12):2329-34. doi: 10.1097/CCM.0b013e3181fa0561.

16.

Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.

Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, Mrozek S, Perbet S, Cayot-Constantin S, Chartier C, Sapin V, Bazin JE, Constantin JM.

Crit Care Med. 2011 Mar;39(3):480-8. doi: 10.1097/CCM.0b013e318206b3ca.

PMID:
21220996
17.

Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.

Fligiel SE, Standiford T, Fligiel HM, Tashkin D, Strieter RM, Warner RL, Johnson KJ, Varani J.

Hum Pathol. 2006 Apr;37(4):422-30.

PMID:
16564916
18.

The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.

Toubi E, Kessel A, Grushko G, Sabo E, Rozenbaum M, Rosner I.

Clin Exp Rheumatol. 2002 Mar-Apr;20(2):221-4.

PMID:
12051403
19.

Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.

Navratilova Z, Zatloukal J, Kriegova E, Kolek V, Petrek M.

Respirology. 2012 Aug;17(6):1006-12. doi: 10.1111/j.1440-1843.2012.02197.x.

PMID:
22591289
20.

The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.

Lorente L, Martín M, Plasencia F, Solé-Violán J, Blanquer J, Labarta L, Díaz C, Borreguero-León JM, Jiménez A, Páramo JA, Orbe J, Rodríguez JA, Salido E.

Crit Care. 2013 May 25;17(3):R94. doi: 10.1186/cc12739.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk